Blocking the channel: A pharmacologically active antagonist of the two-pore-domain potassium ion channel K2P9.1 (TASK-3)

Sep 27, 2011
Blocking the channel: A pharmacologically active antagonist of the two-pore-domain potassium ion channel K2P9.1 (TASK-3)

Treatment of neurological conditions such as sleep–wake control, cognition, and depression could be possible by modulation of the TWIK-related acid-sensitive K+ ion channel (TASK-3, or K2P9.1).

A collaborative effort involving scientists at Merck Research Laboratories (USA) and WuXi AppTec (Shanghai, China) led by Craig A. Coburn has identified a new class of potent small-molecule TASK-3 channel blockers through hypothesis-driven screening and a medicinal chemistry lead optimization program, and their results are reported in ChemMedChem.

The team profiled one compound in detail and demonstrated central nervous system (CNS) target engagement in rodent electroencephalogram (EEG) telemetry models where compound-induced modulation of quantitative EEG power and architecture appeared absent in knock-out animals that lack this channel subunit. This promising lead compound could prove valuable for further exploration in the challenging field of modulators.

Explore further: Video: How did life on Earth begin?

More information: Craig A. Coburn, Discovery of a Pharmacologically Active Antagonist of the Two-Pore-Domain Potassium Channel K2P9.1 (TASK-3), ChemMedChem 2012, 7, No. 1, Permalink to the article: dx.doi.org/10.1002/cmdc.201100351

add to favorites email to friend print save as pdf

Related Stories

Drug prevents seizure progression in model of epilepsy

May 04, 2009

Carnegie Mellon University researchers have identified a new anticonvulsant compound that has the potential to stop the development of epilepsy. The findings are published in the March issue of the journal Epilepsia.

Scorpion has welcome sting for heart bypass patients

Oct 22, 2010

A toxin found in the venom of the Central American bark scorpion (Centruroides margaritatus) could hold the key to reducing heart bypass failures, according to research from the University of Leeds.

Smoking linked to sleep disturbances

Feb 04, 2008

New research shows that cigarette smokers are four times as likely as nonsmokers to report feeling unrested after a night’s sleep. The study, appearing in the February issue of CHEST, the peer-reviewed journal of the American ...

Recommended for you

Chemical biologists find new halogenation enzyme

23 hours ago

Molecules containing carbon-halogen bonds are produced naturally across all kingdoms of life and constitute a large family of natural products with a broad range of biological activities. The presence of halogen substituents ...

Protein secrets of Ebola virus

Sep 15, 2014

The current Ebola virus outbreak in West Africa, which has claimed more than 2000 lives, has highlighted the need for a deeper understanding of the molecular biology of the virus that could be critical in ...

Protein courtship revealed through chemist's lens

Sep 15, 2014

Staying clear of diseases requires that the proteins in our cells cooperate with one another. But, it has been a well-guarded secret how tens of thousands of different proteins find the correct dancing partners ...

Decoding 'sweet codes' that determine protein fates

Sep 15, 2014

We often experience difficulties in identifying the accurate shape of dynamic and fluctuating objects. This is especially the case in the nanoscale world of biomolecules. The research group lead by Professor Koichi Kato of ...

User comments : 0